Steven A. Fischkoff, MD | Authors


Dr. Steven A. Fischkoff on Access to TIL Treatment for Patients With Melanoma

March 14, 2016

Fischkoff says the goal of Lion Biotechnologies is to utilize a central manufacturing facility where medical professionals can submit tumor samples of their patients, and received the proper TIL-based treatment back from the manufacturing facility.